Navigation Links
Novel method predicts impact of a covert anthrax release
Date:7/10/2009

A new statistical method that can estimate the origin and time of an aerosolized release of the pathogen causing anthrax, following detection of the first few cases has been developed by researchers from the Medical Research Council (MRC) Centre for Outbreak Analysis and Modelling at Imperial College London in collaboration with the Health Protection Agency's Microbial Risk Assessment group.

The method, described in an article published April 10 in the open-access journal PLoS Computational Biology, predicts where the most critically affected areas will be following the release of this highly pathogenic agent, which may enable preventative treatment of individuals at risk and protection from the disease.

Previously published methods can estimate the date and scale of anthrax release but not the source location or geographic extent of human exposure. The new method uses information about the first people infected, including when they started to experience symptoms of infection and where they live and work, combined with recent weather information, such as wind direction.

Dr Judith Legrand, lead author of the study from the MRC Centre for Outbreak Analysis and Modelling, said: "We have devised a new way to forecast the future course of a potential outbreak and the people and geographic areas likely to be worst affected."

Anthrax has the potential to cause a large number of deaths in the event of a covert, open air release. If such a release were to occur, it is critical for public health decision makers to evaluate its extent and the potential impact on the population and then to identify the people most at risk of infection as soon as possible.

Dr Judith Legrand added: "It is critical to treat people as soon as possible after exposure to anthrax. While forecasts based on small numbers of early cases are less reliable than those obtained later in an outbreak, we show that treating individuals based on early
'/>"/>

Contact: Dr. Judith Legrand
j.legrand@imperial.ac.uk
44-781-206-5019
Public Library of Science
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Novel Technology Breaks Through Cancer Pain
2. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
3. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
4. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
5. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
6. NIST team develops novel method for nanostructured polymer thin films
7. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
8. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
9. European Expert Consortium Combines Forces to Develop a Novel Pandemic Influenza Vaccine
10. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
11. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Newswire-FirstCall/ -- Sigma-Aldrich Corporation (...MX conference on Tuesday, December 1st at 1:45 PM ...may listen via live audio broadcast over the Inter...a ldrich.com/ . Users can click the "Webcast" i...rich: Sigma-Aldrich is a leading Life Science an...
(Date:11/24/2009)...v. 24 NeurogesX, Inc. (N...d on developing and commercializing novel pain man...Tonno, President and Chief Executive Officer, is s...ay Health Care Conference, to be held December 1-2...ew York. ,, Mr. DiTonno and Stephen Ghiglieri,...
(Date:11/24/2009)...dpoint has been met for patients with advanced-sta...BEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEterna...mpany"), a global biopharmaceutical company focuse...ed positive efficacy data from a Phase 2 study wit...08 (formerly AN-152), in patients with advanced or...
(Date:11/24/2009)...ov. 24 Genomic Health, I...ott, Genomic Health,s Executive Chairman, will pre...Conference in New York City on Tuesday, December 1... and subsequently archived webcast of the presenta...mic Health,s website at http://investor.genomiche...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...A, Calif., July 21 Zenobia Therapeutics, Inc.,(Ze...search at their,facility in La Jolla, California. ...ded and moved into their new laboratory and office...s in the areas of high-throughput,structural biolo...obia will focus on limited population diseases tha...
...D, Calif., July 21 Abingdon Life Sciences,announc...California. The,offices, located at 5963 La Place ...ness Park adjacent to Palomar Airport. Abingdon Li... Diagnostic Development Management,Organization (D...es with,superior services based on an integrated s...
..., Kan., July 18 The 2008 Kansas Day of,Innovation...onference will,be held in Wichita, Kansas, Thursda...00 Corporate Hills Drive. The conference sponsors ...companies in Kansas with an,opportunity to attract...o,be a dynamic event that brings emerging technolo...
Other Biology Technology:Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company 2Abingdon Life Sciences, Inc. Announces Opening of Office in Carlsbad, Ca. 22008 Kansas Day of Innovation Featuring the Fifth Annual Great Plains Capital Conference Scheduled for September 2
(Date:11/24/2009)...e crystallised a protein that may help gut bacteri...could be used by probiotic producers to identify s...ople. , "Probiotics need to interact with cells l...they attach to surfaces in the gut they are more l...ctivity," says Dr Nathalie Juge from the Institute...
(Date:11/24/2009)...he American College of Medical Toxicology (ACMT) h...ication of the Journal of Medical Toxicology (JM... March 2010. It was previously published by the U... of Medical Toxicology , an international, peer-re...nce and practice of medical toxicology. The quart...
(Date:11/24/2009)...tes fish food is a matter of debate. A high-profil...most 50 percent of their carbon from trees and lea...rrestrial and aquatic ecosystems. , But new rese...is not likely to be true. Algae provide a much ric...g to research published this week in the Proceedi...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New Complimentary Wallet Card to Tackle Concussions Head On 58903 1New Complimentary Wallet Card to Tackle Concussions Head On 58903 2Hugh Chatham Adopts Star Trek Technology with the Use of Palm Identify to Prevent Medical ID Theft 58898 1Hugh Chatham Adopts Star Trek Technology with the Use of Palm Identify to Prevent Medical ID Theft 58898 2U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 1U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 2U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 3
... large, clawed frog is helping Oregon Health &...sum of knowledge on Fanconi anemia, a rare, geneti...n the OHSU School of Medicine,s Department of Bioc...port a new approach using eggs of the African claw...is, to understand how the Fanconi anemia proteins ...
...n a mixing of pasta metaphors, Pacific Northwest N...tic attraction to layer reactive biological molecu...tubes. , This configuration can accommodate a wid...sugar monitoring to infectious-agent detection, sa...nt of Energy campus, W.R. Wiley Environmental Mole...
... study by researchers at the University of Califor... that the rate of HIV/AIDS infection in Tijuana, M... previously estimated. The findings are based on ...San Diego and Mexico to create a population-based ... The number of men and women aged 15 to 49 years w...
Other Biology News:Clawed frog helps Fanconi anemia research make leaps 2Clawed frog helps Fanconi anemia research make leaps 3A biosensor layered like lasagna 2HIV/AIDS rates in Tijuana, Mexico increasing at alarming rate 2HIV/AIDS rates in Tijuana, Mexico increasing at alarming rate 3
RosetteSep Anti-Human IgE, 200 ul from StemCell Technologies, Inc.
...t provides a simple and efficient method for purif... PCR mixes. DNA fragments selectively absorbed in ...traction or at room temperature for PCR product wi...NA can be purified with a single prep using YORBIO...
BAS 2500 Image Analysis System from FUJIFILM Life Science
EasySep FITC Selection Kit, Other from StemCell Technologies, Inc.
Biology Products: